HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central Nervous System Cancers, Version 1.2015.

Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. These NCCN Guidelines Insights summarize the NCCN CNS Cancers Panel's discussion and highlight notable changes in the 2015 update. This article outlines the data and provides insight into panel decisions regarding adjuvant radiation and chemotherapy treatment options for high-risk newly diagnosed low-grade gliomas and glioblastomas. Additionally, it describes the panel's assessment of new data and the ongoing debate regarding the use of alternating electric field therapy for high-grade gliomas.
AuthorsLouis Burt Nabors, Jana Portnow, Mario Ammirati, Joachim Baehring, Henry Brem, Paul Brown, Nicholas Butowski, Marc C Chamberlain, Robert A Fenstermaker, Allan Friedman, Mark R Gilbert, Jona Hattangadi-Gluth, Matthias Holdhoff, Larry Junck, Thomas Kaley, Ronald Lawson, Jay S Loeffler, Mary P Lovely, Paul L Moots, Maciej M Mrugala, Herbert B Newton, Ian Parney, Jeffrey J Raizer, Lawrence Recht, Nicole Shonka, Dennis C Shrieve, Allen K Sills Jr, Lode J Swinnen, David Tran, Nam Tran, Frank D Vrionis, Stephanie Weiss, Patrick Yung Wen, Nicole McMillian, Anita M Engh
JournalJournal of the National Comprehensive Cancer Network : JNCCN (J Natl Compr Canc Netw) Vol. 13 Issue 10 Pg. 1191-202 (Oct 2015) ISSN: 1540-1413 [Electronic] United States
PMID26483059 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 by the National Comprehensive Cancer Network.
Topics
  • Adult
  • Central Nervous System Neoplasms (drug therapy, pathology, radiotherapy)
  • Humans
  • Neoplasm Metastasis
  • Practice Guidelines as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: